ECL vs HWKN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: HWKN is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ECL and HWKN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ECL and HWKN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Ecolab is the global leader in water treatment, hygiene, and infection-prevention solutions, serving customers across foodservice, hospitality, healthcare, food and beverage processing, manufacturing, and increasingly high-tech and data-center cooling. The business is built on a razor-and-blade model: Ecolab places dispensing equipment and sensors on-site, then sells the recurring chemicals, service, and software that keep those systems running. Following a 2025 segment reorganization, the company reports through Global Water (formerly Global Industrial), Global Institutional and Specialty, Global Life Sciences, and Global Pest Elimination, with faster-growing units like Life Sciences, Pest Elimination, Global High-Tech, and Ecolab Digital called out as growth engines.

Full ECL guide

Hawkins, Inc. (NASDAQ: HWKN) is a specialty chemicals company founded in 1938 and headquartered in Roseville, Minnesota. It operates through three segments: Water Treatment (chemicals, equipment, and services for potable water, municipal and industrial wastewater, pools, and agriculture), Industrial (chemicals and blends for food, pharmaceutical, energy, electronics, and plating customers), and Health and Nutrition (ingredient distribution and formulation for supplements, functional foods, and personal care). Water Treatment has become the growth engine, expanded aggressively through a string of regional acquisitions such as WaterSurplus.

Full HWKN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ECL drivers: Recurring razor-and-blade model; Water scarcity and hygiene secular demand.
• HWKN drivers: Water Treatment roll-up; Record profitability and margin mix.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most cited risk is valuation: ECL trades at a high price-to-earnings multiple, so slower growth or a guidance miss can pressure the stock even when the underlying business is healthy. For HWKN, the largest risk is valuation: the stock trades at a premium P/E well above the chemicals-industry and peer averages, so any growth disappointment could compress the multiple.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ECL if you believe its drivers more; HWKN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ECL and HWKN guides.

ECL. Ecolab carries a premium valuation, with a trailing P/E in the mid-30s and a forward P/E around 31, reflecting investor confidence in its recurring model and steady growth. Management's FY2026 framework calls for 9 to 11 percent reported sales growth and 12 to 15 percent adjusted EPS growth, supported by pricing, digital, and the pending CoolIT and Ovivo acquisitions. Figures are approximate and move with each quarterly report and share-price changes.

HWKN. Fiscal 2026 (ended in spring 2026) was a record year, with revenue up about 11% and Hawkins crossing $1 billion in sales for the first time. At a trailing P/E in the mid-to-high 30s and roughly 20x EV/EBITDA, the shares trade at a premium to the US chemicals sector average and to close peers. The premium reflects the market pricing in continued acquisition-led water treatment growth.

Headline figures (approximate, JULY 2026): ECL shows revenue (2025) ~$16.1B, q1 2026 revenue ~$4.07B (up ~10% YoY), q1 2026 eps ~$1.52, fy2026 eps guidance ~$8.03 to $8.23; HWKN shows revenue (fy2026, ttm) ~$1.08 billion, net income (fy2026) ~$81.5 million, adjusted ebitda (fy2026) ~$179 million, market cap ~$3.1 billion.

ECL and HWKN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ECL and HWKN exposure against your real portfolio. It is not an investment adviser.